Company Filing History:
Years Active: 2002-2023
Title: The Innovations of Jean-Paul Mutz
Introduction
Jean-Paul Mutz is a notable inventor based in Blotzheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of two patents to his name, Mutz continues to push the boundaries of medical science.
Latest Patents
One of his latest patents is focused on Sacubitril calcium salts. This invention relates to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The calcium salt is useful in treating various conditions and disorders that respond to the inhibition of neutral endopeptidases. Another significant patent involves crystalline macrolides and the process for their preparation, showcasing his expertise in pharmaceutical innovation.
Career Highlights
Jean-Paul Mutz is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach has led to advancements that can potentially improve patient outcomes.
Collaborations
Throughout his career, Mutz has collaborated with talented individuals such as Cornelia Dosenbach and Maximilian Grassberger. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
Jean-Paul Mutz is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in medical treatments. His patents reflect a commitment to innovation and improving healthcare solutions.